DVA.NYSEDavita INC

Form 4: DaVita Inc. Chief Accounting Officer Reports Acquisition and Disposal of Common Stock

Sentiment:

SEC Form 4 Filing


Christopher Michael Berry, Chief Accounting Officer of DaVita Inc., reports acquiring and disposing of common stock and restricted stock units.

Summary

  • Christopher Michael Berry, the Chief Accounting Officer of DaVita Inc., filed a Form 4 detailing changes in beneficial ownership.
  • On March 15, 2025, Berry acquired 3,834 shares of common stock and disposed of an unspecified amount.
  • Following the reported transactions, Berry beneficially owns 15,991 shares of common stock.
  • Berry also holds restricted stock units that are scheduled to vest 50% each on March 15, 2028, and March 15, 2029.
  • Some shares were acquired under the DaVita Employee Stock Purchase Plan.

Sentiment

Score: 5

Explanation: Neutral sentiment as the document primarily reports transactions without expressing an opinion on the company's performance.

Positives

  • The acquisition of shares by a company officer can be seen as a positive signal, indicating confidence in the company's future performance.

Negatives

  • The disposal of shares by a company officer could be interpreted negatively, although the reason for disposal is not specified.

Risks

  • The vesting of restricted stock units is subject to the terms and conditions of the applicable award agreement, which introduces some uncertainty.

Future Outlook

The vesting of restricted stock units on March 15, 2028, and March 15, 2029, suggests a continued relationship between the reporting person and the company.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company officers and directors. This filing is specific to DaVita Inc., a company in the healthcare industry.

Comparison to Industry Standards

  • Comparing Berry's transactions to those of other Chief Accounting Officers in similar healthcare companies would provide a benchmark for assessing the significance of these changes in beneficial ownership.
  • For example, one could compare the size of the stock grants and vesting schedules to those at companies like UnitedHealth Group or HCA Healthcare to gauge whether DaVita's compensation practices are in line with industry norms.

Stakeholder Impact

  • Shareholders may be interested in the transactions of company officers as an indicator of management's confidence in the company.
  • Employees participating in the Employee Stock Purchase Plan are directly impacted by the availability and terms of the plan.

Key Dates

DateDescription
03/15/2025Date of stock acquisition and disposal.
03/15/2028First vesting date (50%) for restricted stock units.
03/15/2029Second vesting date (50%) for restricted stock units.
03/18/2025Date of signature by Attorney-in-Fact.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.